Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation

NCT04392921 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04392921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation
Lead sponsor
Ottawa Hospital Research Institute
Phase
Not applicable
Overall status
Unknown status
Start date
March 7, 2022
Completion date
April 30, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.